American Prospect has published an article for its spring issue that delves deep into the hidden practices of PBMs. "The Hidden Monopolies that Raise Drug Prices," by David Dayen, begins from the perspective of an independent pharmacist. Most patients who use independent pharmacies don't know that the business they are supporting may be struggling to deal with unknown fees and conditions imposed on them by PBMs. Dayen writes, "'I get a prescription, type in the data, click se

The House committee on Oversight and Government Reform held a hearing today on REMS, a regulatory tool that has been co-opted by brand name pharmaceutical companies to thwart generic competition. According to the committee's website, the purpose of the hearing was: To discuss the purpose of using voluntary restricted distribution systems in the pharmaceutical supply chain. To examine how a manufacturer may use a restricted distribution system to delay or block generic competi